Market Research Reports and Industry Reports

FLX Bio Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

FLX Bio Inc (FLX Bio) focuses on the discovery, development and commercialization of novel immuno-oncology agents. The companys pipeline product, FLX925 is a drug targeting the FLT3 mutations which is found in patients with acute myeloid leukemia (AML). FLX925 simultaneously targets a second pathway involved in the AML cell growth, known as CDK4/6. FLX Bio is also developing a pipeline of orally-available small-molecule drugs to activate the immune system and eradicate the cancer. The company has advanced into the clinic a dual-inhibitor drug that target FLT3 and CDK4/6 for the treatment of cancer.FLX Bio is headquartered in South San Francisco, California, the US.

FLX Bio Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
FLX Bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
FLX Bio Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
FLX Bio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
FLX Bio Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
FLX Bio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
FLX Bio Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
FLX Bio Raises USD50 Million in Series B Financing 10
Partnerships 12
Cofactor Genomics Enters into Agreement with FLX Bio 12
Licensing Agreements 13
FLX Bio Enters Into Licensing Agreement with Amgen 13
FLX Bio Inc - Key Competitors 14
FLX Bio Inc - Key Employees 15
FLX Bio Inc - Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Corporate Communications 17
May 31, 2017: FLX Bio Adds Distinguished Immuno-Oncology Experts to its Scientific Advisory Board 17
Dec 12, 2016: FLX Bio appoints new board member 18
Apr 05, 2016: FLX Bio Completes Leadership Team in Immuno-Oncology Drug Discovery 19
Product News 20
12/01/2016: FLX Bio Announces Poster Presentations at the American Society of Hematology Conference on FLX925, a Small Molecule FLT3/CDK4/6 Inhibitor 20
Clinical Trials 21
Sep 21, 2017: FLX Bio Selects Immuno-Oncology Clinical Candidate 21
Mar 31, 2017: FLX Bio to Present Poster at the American Association of Cancer Research Conference on its Lead Immuno-Oncology Program Targeting CCR4 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List Of Tables

List of Tables
FLX Bio Inc, Pharmaceuticals & Healthcare, Key Facts 2
FLX Bio Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
FLX Bio Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
FLX Bio Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
FLX Bio Inc, Deals By Therapy Area, 2011 to YTD 2017 8
FLX Bio Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
FLX Bio Raises USD50 Million in Series B Financing 10
Cofactor Genomics Enters into Agreement with FLX Bio 12
FLX Bio Enters Into Licensing Agreement with Amgen 13
FLX Bio Inc, Key Competitors 14
FLX Bio Inc, Key Employees 15

FLX Bio Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

FLX Bio Inc (FLX Bio) focuses on the discovery, development and commercialization of novel immuno-oncology agents. The companys pipeline product, FLX925 is a drug targeting the FLT3 mutations which is

USD 250View Report

Fieldex Exploration Inc (FLX) - Financial and Strategic SWOT Analysis Review

Fieldex Exploration Inc (Fieldex Exploration) is a mining and mineral exploration company. The company carries out the business of acquisition, exploration and development of base metals, industrial minerals and rare

USD 300View Report

Translate Bio Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Translate Bio Inc (Translate Bio), formerly RaNA Therapeutics Inc is a biotechnology company that develops therapies which targets RNA within cells in the body to selectively activate protein expression. The

USD 250View Report

Distributed Bio Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Distributed Bio Inc (Distributed Bio) is a provider of bioinformatics services. The company offers support of genomic technologies including NextGen sequencing, antibody informatics and computational bioengineering. It provides modern laboratory

USD 250View Report

Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Dec 2017
No. of Pages :24
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube